113372-69-3Relevant academic research and scientific papers
Molybdenum hexacarbonyl and DBU reduction of nitro compounds under microwave irradiation
Spencer, John,Anjum, Nazira,Patel, Hiren,Rathnam, Rajendra P.,Verma, Jason
, p. 2557 - 2558 (2007)
An ethanolic mixture of molybdenum hexacarbonyl and DBU mediates the reduction of nitroarenes to the corresponding anilines in excellent yields in 15-30 minutes under microwave irradiation. Georg Thieme Verlag Stuttgart.
NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
-
Page/Page column 40, (2011/12/02)
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
-
Paragraph 0135, (2013/03/26)
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
Synthesis and biological evaluation of novel prodrugs of anthracyclines for selective activation by the tumor-associated protease plasmin
De Groot, Franciscus M. H.,De Bart, Anton C. W.,Verheijen, Jan H.,Scheeren, Hans W.
, p. 5277 - 5283 (2007/10/03)
New prodrugs of daunorubicin and doxorubicin designed for selective activation by the serine protease plasmin are described. The low toxic prodrugs 3, 4, and 5 are converted to the corresponding cytotoxic drugs upon proteolysis by the tumor-associated protease plasmin. Application of a self- eliminating spacer was essential for enzyme activation. A prodrug containing a chloro-substituted spacer was synthesized with the aim of enhancing the rate of conversion by plasmin. All prodrugs were highly stable in buffer solution and in serum and on the average 15-fold less cytotoxic than the parent drugs in seven human tumor cell lines. A marked in vitro selectivity was demonstrated by incubation of the doxorubicin prodrugs with a plasmin generating MCF-7 breast cancer cell line transfected with urokinase-type plasminogen activator (u-PA) in comparison with the nontransfected nonplasmin generating cell line. Prodrugs 4 and 5 showed the same cytotoxic effect as the free parent drug doxorubicin in the u-PA transfected cells, indicating complete conversion of the prodrug by plasmin. Addition of the plasmin inhibitor Trasylol drastically increased the ID50 values in the u-PA transfected MCF-7 cells for both prodrugs 4 and 5.
THE SYNTHESIS OF 3-CHLORO-4-NITRO- AND 4-AMINO-3-CHLORO-BENZYL ALCOHOLS
Silk, Nicholas A.,Martin, Carl N.
, p. 2133 - 2139 (2007/10/02)
The synthesis of the new compounds 3-chloro-4-nitro- and 4-amino-3-chloro-benzyl alcohols is described.Nitration of 3-chloro-benzyl chloride gives two isomers; the 3-chloro-4-nitrobenzyl chloride isomer is converted to the alcohol via an ester intermediat
